Upgrade

Dermata Therapeutics, Inc.

DRMA

Last
$1.02
Day
-5.6%
1y
-76.4%
5y
-100.0%
52w
-77.9%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1334d
EMA 21
1.14
EMA 50
1.21
EMA 200
2.38
20d high
-15.7%
5y high
-100.0%
5y range
0th
Website · 9 employees · United States

Positions held

Your positions

DRMA isn't in your positions.

Add it to see shares, cost, and P&L here.

Score
-15
Hold
avoid
Signal
Strong Sell
Target
$1.18
Stop
$0.98
Stop distance
3.9%
Target vs last
+15.7%

Fundamentals

Market cap$5.30MEnterprise value-$109,070Trailing P/E—Forward P/E-0.28
PEG—Price / book1.23Beta0.66Dividend yield0.00%
Revenue growth—Earnings growth—Gross margin0.0%Operating margin0.0%
Profit margin0.0%ROE-1.8%ROA-89.9%Debt / equity—
Current ratio2.81Free cash flow-$5.11MAnalyst recommendationnoneMean target$4.00
52w high$4.6652w low$0.95

Quarterly

2026-Q22026-Q12025-Q42025-Q32025-Q22025-Q1
Revenue$0.0M$0.0M$0.0M$0.0M$0.0M—
Op margin——————
Net income-$3.0M-$1.8M-$1.9M-$1.7M-$1.7M—
Gross margin——————
Gross profit——————
Operating income-$3.0M-$1.9M-$1.9M-$1.8M-$1.8M—

Yearly (6y)

20252024202320222021
Revenue$0.0M$0.0M$0.0M$0.0M—
Op margin—————
Net income-$7.6M-$12.3M-$7.8M-$9.6M—
Gross margin—————
Gross profit—————
Operating income-$7.8M-$12.5M-$8.0M-$9.7M—
Headline scan

No flags

• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).

News

DRMA · daily-7.0% over 13 sessions
Close EMA21 EMA50 EMA200
1.041.091.151.211.262026-092026-092026-092026-092026-102026-102026-10
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin
-$3M-$2M-$1M-$1M$0M0%5%10%2025-Q22025-Q32025-Q42026-Q12026-Q2